THY1 and male reproductive organ cancer: True L.D., Zhang H., Ye M., Huang C.-Y., Nelson P.S., von Haller P.D.,Tjoelker L.W., Kim J.-S., Qian W.-J., Smith R.D., Ellis W.J., LiebeskindE.S., Liu A.Y. CD90/THY1 is overexpressed in prostate cancerassociatedfibroblasts and could serve as a cancer biomarker.